Provided by Tiger Trade Technology Pte. Ltd.

MSA Safety

182.18
+0.91000.50%
Post-market: 182.180.00000.00%19:30 EDT
Volume:151.11K
Turnover:27.55M
Market Cap:7.03B
PE:22.65
High:184.28
Open:183.17
Low:181.59
Close:181.27
52wk High:208.92
52wk Low:151.11
Shares:38.58M
Float Shares:36.18M
Volume Ratio:0.65
T/O Rate:0.42%
Dividend:2.14
Dividend Rate:1.17%
EPS(TTM):8.04
EPS(LYR):7.09
ROE:23.66%
ROA:11.07%
PB:5.03
PE(LYR):25.70

Loading ...

Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™

GlobeNewswire
·
Apr 23

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

GlobeNewswire
·
Apr 22

Alterity’s ATH434 Shows Phase 2 Efficacy Signal in MSA on New Composite Scale

TIPRANKS
·
Apr 22

MSA Safety showcases G1 XR SCBA at FDIC International

Reuters
·
Apr 21

MSA Safety schedules first-quarter earnings conference call

Reuters
·
Apr 21

Press Release: Mineros S.A. Updates Market on Special Meeting of Shareholders Scheduled for April 30, 2026, and Confirms Successful Closing of Previously Announced Transaction

Dow Jones
·
Apr 17

Alterity to Spotlight ATH434 MSA Data in Late-Breaker at AAN Meeting

TIPRANKS
·
Apr 16

Alterity Therapeutics to Host Virtual KOL Event to Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

GlobeNewswire
·
Apr 15

Alterity Therapeutics Showcases ATH434 Progress in Virtual MSA KOL Event

TIPRANKS
·
Apr 15

SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial

prnewswire
·
Apr 15

Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress

GlobeNewswire
·
Apr 14

A Look At MSA Safety (MSA) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Apr 02

MSA Safety Coverage Assumed by Jefferies at Hold

Dow Jones
·
Apr 01

MSA Safety assumed with a Hold at Jefferies

TIPRANKS
·
Mar 31

U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks

Reuters
·
Mar 31

MSA Safety Is Maintained at Neutral by Baird

Dow Jones
·
Mar 30

MSA Safety price target lowered to $195 from $205 at Baird

TIPRANKS
·
Mar 30

Alterity Therapeutics Receives Positive FDA Feedback After Type C Meeting on Planned Third-Phase Program

MT Newswires Live
·
Mar 30

MSA Safety FY2025 annual report published; net sales rise to $1.9 billion

Reuters
·
Mar 27

MSA Safety announced annual shareholder meeting via virtual webcast; shares outstanding were 38.8 million as of February 13, 2026

Reuters
·
Mar 27